Poland· PL-100395202
Symtuza
A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing darunavirum + cobicistatum + emtricitabinum + tenofovirum alafenamidum, registered in Poland by Janssen-Cilag International N.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Darunavirum + Cobicistatum + Emtricitabinum + Tenofovirum alafenamidum
- Manufacturer
- Janssen-Cilag International N.V.
- Country
- Poland (PL)
- ATC code
- J05AR22
- ATC class
- Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05413868111583
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesSymtuzaJanssen Products LP
- SpainSYMTUZA 800 MG/150 MG/200 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
- CanadaSYMTUZAJANSSEN INC
- SwitzerlandSymtuza, FilmtablettenJanssen-Cilag AG
- United KingdomSymtuza 800mg/150mg/200mg/10mg tabletsJanssen-Cilag Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Symtuza
- Liechtenstein · Symtuza
- Norway · Symtuza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb1bd0f8-238f-49e2-8008-4b10ecfea43e GET /v1/drugs/eb1bd0f8-238f-49e2-8008-4b10ecfea43e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "800 mg + 150 mg + 200 mg + 10 mg",
"packaging": "05413868111583 ¦ Rpz ¦ EU/1/17/1225/001 ¦ 124902\n1 butelka 30 tabl.\nRpz ¦ EU/1/17/1225/002 ¦ 126068\n3 butelki 30 tabl.",
"substance": "Darunavirum 800 mg + Cobicistatum 150 mg + Emtricitabinum 200 mg + Tenofovirum alafenamidum 10 mg",
"common_name": "Darunavirum + Cobicistatum + Emtricitabinum + Tenofovirum alafenamidum",
"pl_product_id": "100395202",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.